Document is current
Any future updates will be listed below
-
Authors
Wang, Qingbo S. http://orcid.org/0000-0002-9110-5830
Kelley, David R. http://orcid.org/0000-0001-7782-3548
Ulirsch, Jacob http://orcid.org/0000-0002-7947-0827
Kanai, Masahiro http://orcid.org/0000-0001-5165-4408
Sadhuka, Shuvom
Cui, Ran
Albors, Carlos
Cheng, Nathan
Okada, Yukinori http://orcid.org/0000-0002-0311-8472
,
Matsuda, Koichi
Yamanashi, Yuji
Furukawa, Yoichi
Morisaki, Takayuki
Murakami, Yoshinori
Kamatani, Yoichiro
Muto, Kaori
Nagai, Akiko
Obara, Wataru
Yamaji, Ken
Takahashi, Kazuhisa
Asai, Satoshi
Takahashi, Yasuo
Suzuki, Takao
Sinozaki, Nobuaki
Yamaguchi, Hiroki
Minami, Shiro
Murayama, Shigeo
Yoshimori, Kozo
Nagayama, Satoshi
Obata, Daisuke
Higashiyama, Masahiko
Masumoto, Akihide
Koretsune, Yukihiro
Aguet, Francois http://orcid.org/0000-0001-9414-300X
Ardlie, Kristin G.
MacArthur, Daniel G. http://orcid.org/0000-0002-5771-2290
Finucane, Hilary K. http://orcid.org/0000-0003-3864-9828
- License Information
-
More Information
Article History
Received: 23 October 2020
Accepted: 15 April 2021
First Online: 7 June 2021
Competing interests
: D.G.M. is a founder with equity in Goldfinch Bio, and has received research support from AbbVie, Astellas, Biogen, BioMarin, Eisai, Merck, Pfizer, and Sanofi-Genzyme.
